(Reuters) - "We've offered a very full premium and price and I would not
speculate in any other direction," Humer told journalists in a
conference call.
Humer said the group aimed to continue expanding its
diagnostics activities through in-house development and through
the acquisition of technologies.
Read more at Reuters.com Mergers News
speculate in any other direction," Humer told journalists in a
conference call.
Humer said the group aimed to continue expanding its
diagnostics activities through in-house development and through
the acquisition of technologies.
Read more at Reuters.com Mergers News
No comments:
Post a Comment